Impacts of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients with Bladder Cancer Treated with Radical Cystectomy: A Single High-Volume Center Experience

Impacts of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients with Bladder Cancer Treated with Radical Cystectomy: A Single High-Volume Center Experience

(1) Background: Less than 30% of patients with muscle-invasive bladder cancer (MIBC) receive neoadjuvant chemotherapy (NAC), and reasons for underuse remain unclear. One potential explanation is the concern for the increased risk of perioperative morbidity and mortality. The aim of this study is to...

Full description

Bibliographic Details
Main Authors: Flavia Proietti, Rocco Simone Flammia, Leslie Claire Licari, Eugenio Bologna, Alfredo Maria Bove, Aldo Brassetti, Gabriele Tuderti, Riccardo Mastroianni, Antonio Tufano, Giuseppe Simone, Costantino Leonardo
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Personalized Medicine
Subjects:
neoadjuvant chemotherapy
radical cystectomy
bladder cancer
multimodal approach
complications
morbidity
Online Access:https://www.mdpi.com/2075-4426/14/2/212

Internet

https://www.mdpi.com/2075-4426/14/2/212

Similar Items